Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Canntab Therapeutics Ltd > Volume and Price up
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by bpeterson Sep 07, 2018 10:23pm
190 Views
Post# 28583470

RE:RE:RE:Volume and Price up

RE:RE:RE:Volume and Price upIMHO, Here are other reasons for the up tick.

On July 16, 2018 PILL announced that it has engaged Lorne Gertner, one of the world’s foremost investors in the cannabis industry and one of its trailblazing pioneers, as a strategic consultant. Mr. Gertner has significant experience on the boards of a number of publicly traded cannabis companies, including Hiku Brands Company.
 
  • HIKU takeover by CANOPY was completed on Sept 6th. Some of the $$$ from HIKU takeover being reinvested in PILL.  
  • Also Gertners significant contacts could be paying off.
  • News re patent applications?

I'm happy its finally going in the right direction.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities